I. 2017-2018 China Medical Health Innovation Top100 List Second, China's medical health innovation Top100 data analysis (I) Analysis of the ecological distribution of Top100 industry in medical health innovation The medical and health industry includes: medical information industry represented by medical big data and smart medical care; biomedical industry with drugs and medical devices as the main body; individualized health testing and evaluation, consulting services, conditioning and rehabilitation, etc. The health management service industry and emerging industries such as genetic testing, medical imaging, and medical 3D printing. The industrial chain of China's medical and health industry has gradually improved, and emerging industries are emerging. The emerging industries in the health field include pension industry, medical tourism, research and development of nutrition and health products, and research and development of high-end medical devices. The vigorous development of China's medical and health industry in recent years fully reflects that the people are eagerly expecting diversified and personalized health services. Figure 1 Medical health industry ecology In the medical health innovation Top100, medical information technology accounted for the highest proportion, up to 45%; followed by genetic engineering, accounting for 19%; biomedicine ranked third, accounting for 14%. Figure 2 Medical health Top100 segment industry distribution (II) Analysis of Top 100 Regional Layout of Medical Health Innovation According to the analysis of Saizhi Industry Research Institute, due to the high investment, high risk, high return and long development period of the medical and health industry, the industrial development will gather in the park, gather in economically developed areas, and gather in professional intellectual intensive areas. China's medical health industry clusters are mainly distributed in first-tier cities such as Beishangguang, followed by Jiangsu and Zhejiang. Beijing is the center of the list of companies, with 31 companies. It is obvious that the growth of technology-driven enterprises in Beijing has begun to increase, and genetic enterprises and medical artificial intelligence enterprises have begun to appear. Shanghai, Guangdong and Zhejiang have relatively balanced distribution of 25 companies, 19 and 7 companies, and the rest of the list is relatively small. Figure 3 Medical Health Top100 Regional Distribution Beijing has many high-quality scientific and technological research and development centers and a wealth of medical and health talent resources. It has now carried the national medical and health technology research and development, information and technical services. Shanghai's medical health industry base and technology ranks among the top in the country. There are many multinational medical and health enterprises and international financial institutions. It is also the center of research, development, marketing, manufacturing and investment of medical and health multinational companies in China. With the establishment of China's national gene bank in Shenzhen, the promotion of the Shenzhen Municipal Party Committee and the government, and the integration of new generation information technologies such as cloud computing and the Internet of Things, the research and development level in Shenzhen's life science research and bioinformatics security will rapidly increase. It has become China's research and development center in the field of genetic technology and life informatics. (III) Analysis of Top 100 Growth Cycle of Medical Health Innovation From the perspective of the creation time of Top100, China's medical and health enterprises have been established with medical industry innovation companies since 2000. Since they entered the domestic market, they have acquired certain technological advantages and first-mover advantages, and have become the leader in the current industry. From 2000 to 2006, about 2 companies were established each year. Since 2007, the trend has gradually increased. Due to the continuous advancement of China's strategic goals, the medical and health industry is booming. Although the number of companies entering the list declined in 2012, it was followed by 2013. The year has resumed its growth and reached its peak in 2014-2015. It has shown a downward trend in 2016-2017. At this time, leading enterprises have been formed, and enterprises that continue to enter have occupied a large market share. At this time, entering the industry has become Very difficult. Figure 4 Medical health top100 creation time distribution (IV) Medical Health Innovation Top100 Venture Capital Analysis In 2017, medical informatization was favored by investors, accounting for 32.4% of 37 investments; followed by biopharmaceuticals, accounting for 26.5%; genetic engineering accounted for 17.6%, ranking third. The proportion of the three is much higher than other sub-sectors, and the cutting-edge medical technology for improving medical efficiency and related life health is more popular with capital. Figure 5 Analysis of Top 100 Investment Fields in Healthcare The investment round of medical health innovation Top100 is concentrated in early entrepreneurial projects such as A and B rounds, accounting for 61%. Figure 6 Medical Health Top100 Investment Round Distribution (5) Medical Health Top100 represents the enterprise 1. Shanghai Lianying Medical Technology Co., Ltd. Lian Ying Medical is a provider of high-end medical equipment and medical information solutions. Through independent innovation, we provide medical institutions with comprehensive medical solutions covering imaging diagnostic equipment, radiotherapy equipment, service training, and medical IT, popularizing high-end medical care and enhancing service value. In September 2017, Lian Ying Medical received a total of 3.333 billion yuan of Series A financing, with a post-investment valuation of 33.333 billion yuan, jointly led by China Life Insurance Fund and SDIC Innovation Investment Management Co., Ltd., China State-owned Capital Venture Capital Fund, China Investment institutions such as Jinzhide, CITIC Securities, Guokai Kaiyuan and Zhaoyin Telecom jointly funded the completion. 2. Ping An Health Internet Co., Ltd. Established in 2010, Ping An Good Doctor is an Internet health management platform that uses online medical services from family doctors and specialists as an entry point to collaborate with big data mining, analysis and application, using online and offline methods. Provide customers with a variety of personalized and personalized health care management services. In May 2016, the company completed a $50 million Series A round of financing, with IDG Capital, Ping An Innovation Investment Fund and PGA Ventures. 3. Shenyang Kaipu Medical Imaging Technology Co., Ltd. Founded in 2015, Kaipu Image is a medical imaging industry chain service provider. It has two research and production of high-end medical imaging equipment and a third-party medical imaging center. It is dedicated to the development of medical imaging equipment from professional imaging equipment to professional Medical imaging diagnostic services for the entire industry chain platform. In November 2017, it completed a round of financing of 100 million yuan, and the investor was a venture capitalist. 4. Guangdong Tianze Sunshine Kangzhong Medical Investment Management Co., Ltd. Established in 2009, Sunshine Kangzhong is an online medical website where users can make online appointments and access health information. The website also provides services such as expedited medical treatment of small secretaries and agency medical cards. Guangdong Tianze Sunshine Kangzhong Medical Investment Management Co., Ltd. products. In January 2017, it completed tens of millions of yuan of Series A financing, and the investor was Fupu Investment. 5. Shaanxi Anren Overseas Medical Management Co., Ltd. Established in 2016, Anren Overseas Medical is a cross-border medical service provider that provides high-end users with domestic medical examinations, overseas hospital selection, overseas expert appointments, accompanying medical translations, overseas eating, living, and accompanying services. Overseas medical care and other overseas medical docking and services. In March 2017, it completed tens of millions of A round of financing, and the investor was Shaanxi Anshang Investment Group. Bone Glue,Bone Glue Gelatin,Animal Bone Glue,Industrial Grade Bone Glue Hebei Haodong Biological Technology Co.,Ltd. , https://www.hdgelatin.com
2017-2018 medical health Top100 in-depth analysis